Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58

Reuters2026/09/14 23:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Telix Pharmaceuticals: Group Chief Financial Officer Darren Charlton Smith increased his stake via a purchase of 2,071 ordinary shares.
Deal price was AUD 9.66 per share.
Directly held ordinary shares rose to 13,992.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-061944), on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58

You may also like

Crypto prices